Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 51 - 60 of 245 for gsk. (0.07 seconds)

Blockbusters may be good for business, but bad for your...
Global generics company beats estimates. More details...
There could be a big upside in the generics battle. More...
Generic drug maker on a roll. More details...
Has one drug on the market and a nice pipeline. More...
Why science works, but not as quickly as you want it to....
Drug prices likely to become an election issue. More...
Four U.S. biotechs receive more than $25MM for clinical...
Also announces collaboration around kinase high...
Opportunity abounds but many obstacles remain. More...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital